AVENIO Tumor Tissue CGP Automated Kit

For Research Use Only. Not for use in diagnostic procedures.
AVENIO Tumor Tissue CGP Automated Kit
Crucial genomic insights hold the key to clinical cancer research.
But the process of uncovering them can be challenging.

 

The AVENIO Tumor Tissue CGP Automated Kit is a next-generation sequencing (NGS) research use only assay that delivers comprehensive genomic profiling (CGP) of solid tumors, while automating complex CGP steps of library preparation, target enrichment, on-deck pooling and qualification using the AVENIO Edge System and seamless bioinformatics enabled by the expertly curated FoundationOne® Analysis Platform. The kit provides a streamlined, end-to-end workflow, from tissue sample to result generation, ensuring simplicity and efficiency.1

 

The AVENIO Tumor Tissue CGP Automated Kit is the result of a collaboration between Roche and Foundation Medicine two leaders in oncology. This partnership aims to empower researchers to accelerate scientific discovery and innovation in precision oncology.

The AVENIO Tumor Tissue CGP Automated Kit: Focus on the breakthroughs, not the process.

See a video on the AVENIO Tumor Tissue CGP Automated Kit.  

AVENIO Tumor Tissue CGP Automated Kit
robo arm

True walk away automation

Experience up to 24 hours of uninterrupted walkaway time and dedicate more attention to higher value tasks.1,2

Only 3.5 hours of hands-on time for the end-to-end workflow.1,2

award

Robust performance

Overcome sample complexity and have confidence in the quality of your results.3,4

Overall sample pass rate of 99.3%.3

bioinformatics

Insight excellence

Get access to an ever-expanding wealth of insights and turn data into actionable information.2,5

Growing knowledge and technology of Roche and Foundation Medicine, two leaders in oncology.5,6

Leverage a comprehensive solution that enables a simplified and efficient end-to-end CGP workflow.

avenio-pyramid

Experience true walkaway automation and regain time for higher value tasks

The AVENIO Edge System is a fully automated system for NGS library preparation, target enrichment, on-deck pooling, normalization, and quantification.1

Set up your AVENIO Edge System before your shift ends

Create an AVENIO Edge
Load the instrument
walk away and return

And leave the system to do the rest

Automation includes

Achieve robust performance - even with challenging samples.3

Have confidence in every run with a CGP assay that is extensively validated across >5000 FFPE tumor samples.3,4

achieve robust

Deliver insight excellence and generate clear, actionable reports with ease.

Bring the power of two leaders in oncology, Roche and Foundation Medicine, into your lab.5,6

deliver insight

The AVENIO Tumor Tissue CGP Automated Kit: Powerful, precise, and proven with >5000 samples3,4

AVENIO Tumor Tissue CGP Automated Kit enables your lab to adopt CGP without the daunting hurdles that could hinder discoveries. With the expertise and proven technology of Roche and Foundation Medicine, you can finally perform CGP with efficiency and renewed confidence.

Bring the Power of Foundation Medicine® and Roche into Your Lab

Bring the power of foundation medicine

    Reference

  1. AVENIO Tumor Tissue CGP Automated Kit Instructions for Use v1 2024.
  2. Y. Li, et al. AVENIO Tumor Tissue CGP Automated Assay: End-to-End Solution with High Sample Pass Rate and Precision. Poster presented at Association of Molecular Pathology, November 2024.
  3. Data on file with Roche.
  4. Serena Li. Comparative Analysis of Variant Reporting and HRD Performance: Evaluating AVENIO Tumor Tissue CGP Automated Assay Against F1CDx Assay and PGDx elio Tests. Poster presented at Association of Molecular Pathology, November 2024.
  5. Data on file with Roche. Available at: https://www.foundationmedicine.com/info/about-our-products-and-services. (Accessed September 2024).
  6. Roche. Oncology. Available at: https://www.roche.com/solutions/focus-areas/oncology. (Accessed November 2024).
  7. AVENIO Tumor Tissue CGP Automated Kit Site Preparation Guide v1.0
  8. Killeen Kirkconnell, et al. High Analytical Sensitivity and Specificity of the AVENIO Tumor Tissue CGP Automated Assay for Detecting Genomic Alterations in FFPE Tumor Tissue. Poster presented at Association of Molecular Pathology, November 2024.
  9. Chen KT, et al. Oncologist. 2023 Aug 3;28(8):691 698.
  10.  Mack PC, et al. The Oncologist. 2024, 29, e984 e996.
  11.  navify® Mutation Profiler Instructions for v2.6 Instructions for Use 2023.
  12. Foundation Medicine Biopharma services. Available at: https://www.foundationmedicine.com/info/biopharma-overview. (Accessed September 2024).
  13. AVENIO Connect v2.3 Instructions for Use 2024.
To place an order or ask a question
Contact us

Ordering Information

AVENIO Tumor Tissue CGP Automated Kit delivers comprehensive genomic profiling (CGP) of solid tumors while automating complex CGP steps of library preparation, target enrichment, on-deck pooling and qualification using the AVENIO Edge System. The kit provides a streamlined, end-to-end workflow, from tissue sample to result generation, ensuring simplicity and efficiency.

 

The kit is available in four configurations.

View Full Table
close
Material Description Material Number
AVENIO Tumor Tissue CGP Automated Kit 1 - 24 rxn 10247177001
AVENIO Tumor Tissue CGP Automated Kit 2 - 24 rxn 10247185001
AVENIO Tumor Tissue CGP Automated Kit 3 - 24 rxn 10247193001
AVENIO Tumor Tissue CGP Automated Kit 4 - 24 rxn 10247207001



The AVENIO product portfolio is for Research Use Only. Not for use in diagnostic procedures.

To place an order or ask a question
Contact us